Aethlon Medical: Recent News and Updates

Company Profile

Aethlon Medical Inc. (AEMD) is a medical therapeutic company focused on developing and commercializing innovative treatments for cancer and other life-threatening diseases.

Recent News

June 27, 2024: Aethlon Medical announced financial results for the fiscal first quarter ended June 30, 2024. The company reported revenue of $5.2 million and a net loss of $1.9 million.

August 14, 2023: Aethlon Medical released financial results for the first quarter ended June 30, 2023. The company had cash and cash equivalents of $4.3 million and total assets of $14.2 million.

June 20, 2024: Aethlon Medical announced that it would release fiscal first quarter financial results and host a conference call on August 14.

June 6, 2024: Aethlon Medical presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, where it shared data on its investigational cancer therapy, Hemopurifier.

Conclusion

Aethlon Medical is a rapidly growing company with a promising pipeline of investigational therapies. The recent financial results and clinical data updates provide investors with a positive outlook for the company's future. As the company continues to develop and commercialize its treatments, it is expected to make a significant impact on the healthcare industry and the lives of patients around the world.